HG Schneider, L Lam, A Lokuge, H Krum, MT … - Ann Intern Med, 2009 - Am Coll Physicians Background: B-type natriuretic peptide (BNP) is used to diagnose heart failure,
but the effects of using the test on all dyspneic patients is uncertain. ...
Objective: To assess whether BNP testing alters clinical outcomes and ... Cited by 4 - Related articles - All 4 versions
[CITATION] Society Of America. Evaluation of patients for ventricular dysfunction and heart failure
- ►tripod.com [PDF] M Pfisterer, P Buser, H Rickli, M Gutmann, P … - JAMA, 2009 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 19 - Related articles - All 6 versions
DS Lee, P Gona, RS Vasan, MG Larson, EJ … - Circulation, 2009 - Am Heart Assoc From the Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
(DSL, JVT); University Health Network, University of Toronto, Toronto, Ontario,
Canada (DSL); Framingham Heart Study of the National Heart, Lung, and Blood ... Cited by 4 - Related articles - All 5 versions
DS Lee, PC Austin, TA Stukel, DA Alter, A … - The American Journal of Medicine, 2009 - Elsevier BACKGROUND: The mortality impact of recurrent cardiac hospitalizations has not
been delineated in community-based heart failure patients. We determined if a
“dose-dependent” relationship exists between heart failure events and ... Cited by 5 - Related articles - All 19 versions
IL Pina, C O'Connor - JAMA, 2009 - Am Med Assoc The current status of BNP in heart failure has been the result of an important
historic journey. In 1981, de Bold et al 1 injected myocardial homogenates into
nondiuretic rats. The atrial muscle extract increased sodium and chloride ... Cited by 4 - Related articles - All 2 versions
[CITATION] ADHERE Scientific Advisory Committee and Investigators
KF Adams Jr, GC Fonarow, CL Emerman, TH … - Characteristics and outcomes of patients hospitalized for … Cited by 5 - Related articles
M Schou, F Gustafsson, P Corell, CN Kistorp, … - American heart journal, 2007 - Elsevier N-terminal pro–brain natriuretic peptide (NT-proBNP) carries prognostic
information in patients with chronic heart failure and predicts risk for
mortality and cardiovascular events. It is unknown whether NT-proBNP ... Cited by 5 - Related articles - All 5 versions
- ►onlinejacc.org S Masson, R Latini, IS Anand, S Barlera, L … - Journal of the American College of Cardiology, 2008 - Am Coll Cardio Found Background: Although previous studies examined the prognostic value of repeated
determinations of BNP in HF, there are only limited data on the clinical utility
of serial measurements of the inactive peptide NT-proBNP in a large ... Cited by 6 - Related articles - All 4 versions
- ►nursing2008.com JHW Rutten, EW Steyerberg, F Boomsma, … - American heart journal, 2008 - phx1.medscape.com Obviously, the effect of introduction of natriuretic peptide testing on clinical
outcome and cost savings strongly depends on the way medical care is organized
and delivered. Hence, findings may vary from region to region and, ... Cited by 6 - Related articles - All 32 versions
